NEWAMSTERDAM PHARMA COMPANY's ticker is and the CUSIP is N62509117. A total of 21 filers reported holding NEWAMSTERDAM PHARMA COMPANY in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON CORP | 21,333 | $40,533 | 0.10% |
| Frazier Life Sciences Management, L.P. | 500,333 | $920,613 | 0.07% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 733,327 | $1,357 | 0.05% |
| Exos TFP Holdings LLC | 93,932 | $172,835 | 0.04% |
| EcoR1 Capital, LLC | 66,665 | $883,978 | 0.03% |
| Bain Capital Life Sciences Investors, LLC | 100,000 | $184 | 0.02% |
| Affinity Asset Advisors, LLC | 37,000 | $68,450 | 0.02% |
| RA Capital Management | 333,333 | $613,333 | 0.01% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 92,787 | $170,728 | 0.00% |
| Westchester Capital Management, LLC | 31,189 | $57,699 | 0.00% |